Home/Torqur/Dr. Thomas Ladner
DT

Dr. Thomas Ladner

Non-Executive Board Member & Secretary

Torqur

Therapeutic Areas

Torqur Pipeline

DrugIndicationPhase
Bimiralisib (PQR309)Actinic KeratosisPhase 2
Next-gen PI3K/mTOR inhibitorsOncologyPre-clinical